Leaflet DORITHRICIN MINT 0.5mg / 1.0mg / 1.5mg lozenges


Indicated for: sore throat; oropharyngeal infections

Route of administration: oromucosal

Substance: tyrothricin + benzalkonium chloride + benzocaine (topical antibiotic, quaternary antiseptic and local anesthetic)

ATC: R02AA20 (Respiratory system | Throat preparations | Antiseptics)

Precautions:
Anaphylaxis
Anaphylaxis

Risk of severe allergic reaction. Seek urgent medical help if serious symptoms occur.

General data about DORITHRICIN MINT 0.5mg / 1.0mg / 1.5mg

  • Substance: tyrothricin + benzalkonium chloride + benzocaine
  • Date of last drug list: 01-03-2025
  • Commercial code: W70916001
  • Concentration: 0.5mg / 1.0mg / 1.5mg
  • Pharmaceutical form: lozenges
  • Quantity: 20
  • Product type: generic
  • Prescription restrictions: OTC - Over the Counter = medicines that do not require a prescription.

Marketing authorisation

  • Manufacturer: MEDICE ARZNEIMITTEL PUTTER GMBH & CO. KG - GERMANIA
  • Holder: MEDICE PHARMA GMBH & CO. KG - GERMANIA
  • Number: 15820/2025/01
  • Shelf life: 3 years